Medical imaging in pregnancy

Medical imaging in pregnancy may be indicated because of pregnancy complications, intercurrent diseases or routine prenatal care.
Options.
Options for medical imaging in pregnancy include the following:
Magnetic resonance imaging (MRI).
Magnetic resonance imaging (MRI), without MRI contrast agents, is not associated with any risk for the mother or the fetus, and together with medical ultrasonography it is the technique of choice for medical imaging in pregnancy.
Safety.
For the first trimester, no known literature has documented specific adverse effects in human embryos or fetuses exposed to non-contrast MRI during the first trimester. During the second and third trimesters, there is some evidence to support the absence of risk, including a retrospective study of 1737 prenatally exposed children, showing no significant difference in hearing, motor skills or functional measures after a mean follow-up time of 2 years.
Gadolinium contrast agents in the first trimester is associated with a slightly increased risk of a childhood diagnosis of several forms of rheumatism, inflammatory disorders, or infiltrative skin conditions, according to a retrospective study including 397 infants prenatally exposed to gadolinium contrast. In the second and third trimester, gadolinium contrast is associated with a slightly increased risk of stillbirth or neonatal death, by the same study. Hence, is recommended that gadolinium contrast in MRI should be limited, and should only be used when it significantly improves diagnostic performance and is expected to improve fetal or maternal outcome.
Common uses.
MRI is commonly used in pregnant women with acute abdominal pain and/or pelvic pain, or in suspected neurological disorders, placental diseases, tumors, infections, and/or cardiovascular diseases. Appropriate use criteria by the American College of Radiology give a rating of ≥7 (usually appropriate) for non-contrast MRI for the following conditions:
Radiography and nuclear medicine.
Fetal effects by radiation dosage.
Health effects of radiation may be grouped in two general categories:
The determinstistic effects have been studied at for example survivors of the atomic bombings of Hiroshima and Nagasaki and cases of where radiation therapy has been necessary during pregnancy:
The intellectual deficit has been estimated to be about 25 IQ-points per 1,000 mGy at 10 to 17 weeks of gestational age.
Radiation-induced breast cancer.
The risk for the mother of later acquiring radiation-induced breast cancer seems to be particularly high for radiation doses during pregnancy.
This is an important factor when for example determining whether a ventilation/perfusion scan (V/Q scan) or a CT pulmonary angiogram (CTPA) is the optimal investigation in pregnant women with suspected pulmonary embolism. A V/Q scan confers a higher radiation dose to the fetus, while a CTPA confers a much higher radiation dose to the mother's breasts. A review from the United Kingdom in 2005 considered CTPA to be generally preferable in suspected pulmonary embolism in pregnancy because of higher sensitivity and specificity as well as a relatively modest cost.